Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Turcot syndrome × camrelizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 36 Carcinoma, Non-Small-Cell Lung 29 Triple Negative Breast Neoplasms 23 Nasopharyngeal Carcinoma 22 Stomach Neoplasms 21 Esophageal Squamous Cell Carcinoma 19 Esophageal Neoplasms 19 Breast Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 14 Colorectal Neoplasms 12 Uterine Cervical Neoplasms 11 Sarcoma 10 Pancreatic Neoplasms 9 Lung Neoplasms 9 Recurrence 7 Neoplasm Metastasis 7 Melanoma 6 Hodgkin Disease 6 Cholangiocarcinoma 6 Liver Neoplasms 5 Biliary Tract Neoplasms 5 Small Cell Lung Carcinoma 4 Osteosarcoma 4 Neoplasms 4 Advanced Solid Tumor 4 Advanced Gastric Cancer 4 Solid Tumor 3 Respiratory Tract Diseases 3 Rectal Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3

Interventions

pembrolizumab 10 Nivolumab 9 Ipilimumab 4 avelumab 3 Neoadjuvant Therapy 3 sintilimab 2 durvalumab 2 atezolizumab 2 Specimen Handling 2 Immune Checkpoint Inhibitors 2 toripalimab 1 tislelizumab 1 spartalizumab 1 relatlimab 1 regorafenib 1 fludarabine phosphate 1 fludarabine 1 dostarlimab 1 denileukin diftitox 1 danvatirsen 1 camrelizumab 1 XELOX 1 Taxes 1 Surgical Procedures, Operative 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Oxaliplatin 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06215677 2025-09-05

NITDC

Peking Union Medical College Hospital

Phase NA Recruiting

Gastrointestinal

Turcot syndrome, Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡